• Evolution of Virus inactivation methods in manufacture of biologics

  • By: DD ENTERPRISES
  • Podcast

Evolution of Virus inactivation methods in manufacture of biologics

By: DD ENTERPRISES
Listen for free

  • Summary

  • Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses. DNA-based herpesviruses and RNA-based retroviruses are examples of enveloped viruses; DNA-based adenoviruses and RNA-based parvoviruses are examples of nonenveloped viruses.


    Visit Site>> Click Here
    Copyright 2024 DD ENTERPRISES
    Show more Show less
Episodes
  • Evolution of Virus inactivation methods in manufacture of biologics

    Evolution of Virus inactivation methods in manufacture of biologics
    May 29 2024

    Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


    Visit Site>> Click Here
    Show more Show less
    19 mins
Social Sciences
Show more Show less

What listeners say about Evolution of Virus inactivation methods in manufacture of biologics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available